High-throughput screening of glucocorticoid-induced enhancer activity reveals mechanisms of stress-related psychiatric disorders

Proc Natl Acad Sci U S A. 2023 Dec 5;120(49):e2305773120. doi: 10.1073/pnas.2305773120. Epub 2023 Nov 27.

Abstract

Exposure to stressful life events increases the risk for psychiatric disorders. Mechanistic insight into the genetic factors moderating the impact of stress can increase our understanding of disease processes. Here, we test 3,662 single nucleotide polymorphisms (SNPs) from preselected expression quantitative trait loci in massively parallel reporter assays to identify genetic variants that modulate the activity of regulatory elements sensitive to glucocorticoids, important mediators of the stress response. Of the tested SNP sequences, 547 were located in glucocorticoid-responsive regulatory elements of which 233 showed allele-dependent activity. Transcripts regulated by these functional variants were enriched for those differentially expressed in psychiatric disorders in the postmortem brain. Phenome-wide Mendelian randomization analysis in 4,439 phenotypes revealed potentially causal associations specifically in neurobehavioral traits, including major depression and other psychiatric disorders. Finally, a functional gene score derived from these variants was significantly associated with differences in the physiological stress response, suggesting that these variants may alter disease risk by moderating the individual set point of the stress response.

Keywords: SNPs; STARR-seq; glucocorticoids; psychiatric disorders.

MeSH terms

  • Genetic Predisposition to Disease
  • Genome-Wide Association Study
  • Glucocorticoids*
  • High-Throughput Screening Assays
  • Humans
  • Mental Disorders* / genetics
  • Polymorphism, Single Nucleotide
  • Quantitative Trait Loci
  • Regulatory Sequences, Nucleic Acid

Substances

  • Glucocorticoids